BRIDGE-HBV
BRIDGE-HBV: Improving hepatitis B testing, vaccination and treatment uptake for immigrants in Canada
Immigrants from countries where hepatitis B is common carry a disproportionate share of chronic hepatitis B in Canada, yet remain under-screened, under-diagnosed and under-treated, even though testing, vaccination and treatment are safe and effective. Many models of care were designed without immigrant communities at the table.
Synthesize interventions that enhance hepatitis B testing, linkage to care, vaccination and treatment uptake.
Identify barriers and facilitators to hepatitis B vaccination, and to the other interventions, including language, legal status, trauma, discrimination and competing settlement priorities.
Co-produce recommendations with community and health-system partners.
The funding period ended in 2025. Analysis is underway for three reviews: interventions to enhance hepatitis B testing, linkage to care, vaccination and treatment uptake; barriers and facilitators to vaccination; and barriers and facilitators to the other interventions.
The study pairs structured evidence synthesis with integrated knowledge translation: community and health-system partners help shape the questions, interpret findings and frame recommendations throughout, so that what emerges is grounded, acceptable and actionable.
- Review of interventions to enhance hepatitis B testing, linkage to care, vaccination and treatment uptake
- Review of barriers and facilitators to hepatitis B vaccination
- Review of barriers and facilitators to the other interventions
- Community-informed recommendations for hepatitis B models of care
Led with Dr. Christina Greenaway (McGill University), with community organizations serving newcomers and refugees.
Enquire about BRIDGE-HBV
Findings, collaborations and trainee projects on hepatitis B care for immigrant communities.